Evolent Health (EVH) Tops Q3 EPS by 1c

Evolent Health (NYSE: EVH) reported Q3 EPS of ($0.03), $0.01 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $264.6 million versus the consensus estimate of $263.77 million.

GUIDANCE:

Evolent Health sees Q4 2020 revenue of $249-264 million, versus the consensus of $266.6 million.

For earnings history and earnings-related data on Evolent Health (EVH) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Bernstein SocGen Reiterates Outperform Rating on Fervo Energy (FRVO)
• John Wiley & Sons, Inc. (WLY) Tops Q4 EPS by 12c; offers outlook